␤ 1 and ␤ 2 adrenergic receptors (AR) regulate the intrinsic contraction rate in neonatal mouse cardiac myocytes through distinct signaling pathways. It has been shown that stimulation of ␤ 1 ARs leads to a protein kinase A-dependent increase in contraction rate. In contrast, stimulation of ␤ 2 ARs has a biphasic effect on contraction rate, with an initial protein kinase A-independent increase followed by a sustained decrease that is blocked by pertussis toxin. The ␤ 2 AR undergoes agonist-induced endocytosis in cardiac myocytes while the ␤ 1 AR remains on the cell surface. It has been shown that a PDZ domain binding motif at the carboxyl terminus of ␤ 1 AR interacts with the postsynaptic density protein PSD-95 when both are expressed in HEK293 cells. We found that mutation of this PDZ binding motif in the ␤ 1 AR (␤ 1 AR-PDZ) enabled agonist-induced internalization in cardiac myocytes. Moreover, stimulation of ␤ 1 AR-PDZ had a biphasic effect on the myocyte contraction rate similar to that observed following stimulation of the ␤ 2 AR. The secondary decrease in the contraction rate was mediated by G i and could be blocked by pertussis toxin. Furthermore, a non-selective endocytosis inhibitor, concanavalin A, inhibited the internalization of wild type ␤ 2 AR and the mutated ␤ 1 AR-PDZ, and blocked the coupling of both receptors to G i . Finally, treating myocytes with a membrane-permeable peptide representing ␤ 1 AR PDZ motif caused the endogenous ␤ 1 AR to behave like ␤ 1 AR-PDZ. These studies suggest that association of the ␤ 1 AR with PSD-95 or a related protein dictates signaling specificity by retaining the receptor at the cell surface and preventing interaction with G i .
␤ 1 and ␤ 2 adrenergic receptors (AR) regulate the intrinsic contraction rate in neonatal mouse cardiac myocytes through distinct signaling pathways. It has been shown that stimulation of ␤ 1 ARs leads to a protein kinase A-dependent increase in contraction rate. In contrast, stimulation of ␤ 2 ARs has a biphasic effect on contraction rate, with an initial protein kinase A-independent increase followed by a sustained decrease that is blocked by pertussis toxin. The ␤ 2 AR undergoes agonist-induced endocytosis in cardiac myocytes while the ␤ 1 AR remains on the cell surface. It has been shown that a PDZ domain binding motif at the carboxyl terminus of ␤ 1 AR interacts with the postsynaptic density protein PSD-95 when both are expressed in HEK293 cells. We found that mutation of this PDZ binding motif in the ␤ 1 AR (␤ 1 AR-PDZ) enabled agonist-induced internalization in cardiac myocytes. Moreover, stimulation of ␤ 1 AR-PDZ had a biphasic effect on the myocyte contraction rate similar to that observed following stimulation of the ␤ 2 AR. The secondary decrease in the contraction rate was mediated by G i and could be blocked by pertussis toxin. Furthermore, a non-selective endocytosis inhibitor, concanavalin A, inhibited the internalization of wild type ␤ 2 AR and the mutated ␤ 1 AR-PDZ, and blocked the coupling of both receptors to G i . Finally, treating myocytes with a membrane-permeable peptide representing ␤ 1 AR PDZ motif caused the endogenous ␤ 1 AR to behave like ␤ 1 AR-PDZ. These studies suggest that association of the ␤ 1 AR with PSD-95 or a related protein dictates signaling specificity by retaining the receptor at the cell surface and preventing interaction with G i .
␤ adrenergic receptors (␤ 1 AR, ␤ 2 AR, and ␤ 3 AR) 1 are heptahelical G protein-coupled receptors (GPCRs) that mediate physiological responses to the hormone epinephrine and the neurotransmitter norepinephrine. Both ␤ 1 and ␤ 2 ARs are expressed in the heart and play critical roles in regulating cardiac function in animals (1) . In vitro studies show that ␤ 1 and ␤ 1 ARs have very similar signaling properties when expressed in undifferentiated cell lines (2) . However, evidence also suggests that they have different signaling properties in differentiated cells in vivo (3, 4) . Moreover, these receptors may differ in other functional parameters such as desensitization (5) . ␤ 1 AR knockout mice lack the normal inotropic and chronotropic response to the adrenergic agonist, isoproterenol (6) , whereas these responses are preserved in ␤ 2 AR knockout mice (7) .
We recently reported that ␤ 1 and ␤ 2 ARs regulate contraction rate in mouse neonatal myocytes through different signal transduction pathways (8) . Activated ␤ 1 AR couples only to G s and leads to a PKA-dependent increase in contraction rate. Activated ␤ 2 AR undergoes sequential coupling to G s and G i and has a biphasic effect on contraction rate, with an initial PKAindependent increase followed by a sustained decrease that can be blocked by pertussis toxin (8) . Recent biochemical evidence suggests that the functional differences between ␤ 1 and ␤ 2 AR in cardiac myocytes may be mediated in part by subtype-specific targeting in the myocyte plasma membrane. Fractionation studies show that ␤ 2 ARs are concentrated in caveolae structures, whereas ␤ 1 ARs are mainly distributed in non-caveolar membrane on the cardiac myocyte plasma membrane (9, 10) . Moreover, studies show that ␤ 2 AR signaling can modulate L-type Ca 2ϩ channel activity in distinct subcellular microdomains in hippocampal neurons and cardiac myocytes (11) (12) (13) . These observations suggest that distinct signaling complexes may exist in cardiac myocytes to conduct ␤ 1 and ␤ 2 AR signaling.
Evidence also shows that GPCRs can form complexes with downstream effectors to facilitate signaling. ␤ 2 AR has been shown to associate with AKAP79 and Gravin, which are scaffolding proteins that connect ␤ 2 AR to PKA, PKC, PP2A, and/or L-type Ca 2ϩ channels (11, 14 -16) . GPCRs can also be recruited into the signaling complexes through the receptor carboxylterminal PDZ domain binding motifs, which directly interact with PDZ domain-containing scaffolding proteins. It has been shown that the ␤ 2 AR carboxyl-terminal PDZ motif interacts with the Na ϩ /H ϩ exchanger regulatory factor (NHERF, also known as EBP50) (17) . This interaction is critical for the receptor recycling after sequestration from the cell surface, and affects Na ϩ /H ϩ exchange in HEK293 cells (17, 18) . Recent reports show that the ␤ 1 AR PDZ motif can interact with postsynaptic scaffolding proteins PSD-95 (SAP90) and MAGI-2 in HEK293 cells (19, 20) . A homologue of PSD-95, SAP97, is expressed in the heart and associates with potassium channels in cardiac myocytes (21, 22) ; however, the functional role of an interaction between the ␤ 1 AR and a PDZ domain-containing scaffold proteins in cardiac myocytes has not been reported.
To investigate the functional role of the PDZ binding motif in subtype-specific signaling by the ␤ 1 AR, we expressed wild type and a PDZ mutant (␤ 1 AR-PDZ) in neonatal myocytes from * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.␤ 1 /␤ 2 AR knockout mice. In comparison to wild type ␤ 1 AR, ␤ 1 AR-PDZ undergoes significant internalization upon agonist stimulation. Moreover, like the ␤ 2 AR, the ␤ 1 AR-PDZ couples to both G s and G i in cardiac myocytes. Coupling of both ␤ 2 AR and ␤ 1 AR-PDZ to G i is dependent on receptor internalization and can be blocked by concanavalin A. These results demonstrate that association of ␤ 1 AR with PSD-95 or a related protein dictates signaling specificity by retaining the receptor at the cell surface and preventing interaction with G i .
EXPERIMENTAL PROCEDURES

Culture and Adenovirus Infection of Neonatal Mouse Ventricular
Myocytes-Spontaneously beating neonatal cardiac myocytes were prepared from hearts of 1-to 2-day-old mouse pups (from wild type, ␤ 1 AR-KO, ␤ 2 AR-KO, and ␤ 1 /␤ 2 AR-KO mice) as previously described (8) with some modification. Briefly, hearts were excised, the atria were removed, and the ventricles were minced and digested at 37°C for 3 ϫ 15 min in calcium-free HEPES-buffered Hanks' solution, pH 7.4, plus 300 unit/ml collagenase type II (Invitrogen, Carlsbad, CA). The isolated myocytes were collected from the second and third digestions. To reduce the contribution of non-myocardial cells, the isolated cells were preplated for 1 h at 37°C. The myocyte-enriched cells remaining in suspension were plated in 35-mm dishes for contraction rate studies, in 12-well plates for ELISA, in 12-well plates with coverslips for immunocytochemistry, or in 10-cm dishes for Western blot and ligand binding assays. Culture dishes or coverslips were precoated with 10 g/ml mouse laminin at 37°C for 24 h. Myocyte cultures were maintained in Dulbecco's modified Eagle's media containing 10% horse serum, 5% bovine fetal serum, and 1ϫ penicillin/streptomycin. The culture media was changed every 24 h. To further reduce fibroblast contamination, myocytes were cultured in the presence of 10 M cytosine-␤-D-arabinofuranoside (Sigma) during the first 24 h to block fibroblast proliferation.
Recombinant adenoviruses encoding amino-terminal FLAG-tagged mouse ␤ 2 AR or HA-tagged mouse ␤ 1 AR or ␤ 1 AR-PDZ (the ␤ 1 AR carboxyl-terminal PDZ motif ESKV was mutated into EAAA) were generated with the pAdEasy system (Q.biogen, Carlsbad, CA). The virus titer was obtained by optical density as recommended by the manufacturer (Q.biogen). HA-␤ 1 AR virus was used to infect neonatal myocytes with different multiplicities of infection (m.o.i.) after the myocytes were cultured for 24 h. The myocytes were incubated with virus-containing media for 2 h at 37°C. The virus media was then removed and replaced with fresh media. The infected myocyte culture was maintained for 2 days before being used for subsequent experiments.
Measurement of Myocyte Contraction Rate-Measurement of the spontaneous contraction rate was carried out as described previously (8) with modifications. Briefly, myocytes were cultured in 35-mm dishes to obtain a uniformly beating syncytium. After 72 h in culture, the culture media was replaced with fresh media buffered with 20 mM HEPES, pH 7.4, at 37°C for at least 1 h before contraction rate studies. To measure myocyte contraction rate, culture dishes were placed in a temperature regulation apparatus positioned on the stage of an inverted microscope. The culture was equilibrated for 10 min before the addition of the nonselective ␤AR agonist isoproterenol (10 M final concentration). A video camera connecting the microscope to a computer with Metamorph image software was used to acquire images (Universal Imaging). Stacks of myocyte images were stream-acquired with Metamorph Flashbus at 2-min intervals for 10 min before and 30 min after adrenergic ligand stimulation. The images were analyzed with Metamorph Object-Track, and the resulting contraction rate data were plotted using Microsoft Excel. All assays were also recorded on videotape.
For the time course experiments, statistical significance between groups was analyzed with two-way analysis of variance. Analysis was done with Prism software (Graph Pad Software, Inc., San Diego, CA).
Measurement of cAMP Accumulation-To measure intracellular cAMP, myocytes were cultured in 12-well plates (2.5 ϫ 10 5 cells per well). Cells were incubated for 30 min at 37°C with 1 mM isobutylmethylxanthine (Sigma) immediately before the addition of the agonist isoproterenol (10 M) for 10 or 30 min at room temperature. The assay was terminated by the aspiration of the incubation buffer and the addition of 0.5 ml of 100% ice-cold ethanol to each well. The cell lysates were then collected. Aliquots were dried in a spin vacuum, and cAMP in the residue was determined using a radioimmunoassay (Amersham Biosciences)
Drugs and Drug Treatment-Tat and Tat-Scr-⑀R peptides were generous gifts from Daria Mochly-Rosen (23). Tat-PDZ consisting of Tat and amino-terminal cysteine-bridge linked 466 
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COOϪ of ␤ 1 AR was synthesized in the Stanford Core facility. Neonatal myocytes were preincubated at 37°C with concanavalin A (conA, 400 g/ml, Sigma, MO) for 30 min. or peptides (Tat, Tat-Scr-⑀R or Tat-PDZ, 1 M) for 25 min. before isoproterenol (10 M, sigma, MO) or forskolin (10 M, sigma, MO) exposure. For some contraction assays, PTX (0.75 g/ml, Sigma, MO) was used together with conA or the peptides. PTX treatment was carried out as described previously (8) .
Immunoflouresence Microscopy-Myocytes were cultured in 12-well plates with coverslips and infected with the FLAG-␤ 2 AR, HA-␤ 1 AR, or HA-␤ 1 AR-PDZ adenoviruses as described above. Myocytes were fixed with 1ϫ PBS containing 5% paraformaldehyde and permeabilized with 1ϫ PBS containing 1% Nonidet P-40. Cells were then stained with anti-FLAG M1 antibody (mouse monoclonal IgG 2b , 1:600 dilution, Sigma) or anti-HA 16b12 antibody (mouse monoclonal IgG 1 , 1:600 dilution, Covance, Berkeley, CA). The primary antibodies were detected with fluorescein isothiocyanate-conjugated goat anti-mouse IgG (1:200 Fisher, Pittsburgh, PA). The images were acquired with a Ziss Axioplan 2 Imaging microscope (Thornwood, NY).
Ligand Binding Assay-Membrane proteins were prepared from ␤ 2 AR-KO myocytes and adenovirus-infected ␤ 1 /␤ 2 AR-KO myocytes as described above. The myocyte cultures were rinsed with ice-cold 1ϫ PBS before harvesting with 20 mM HEPES, pH 7.4, buffer containing 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml benzamidine. The collected cells were disrupted by passing the suspension through a 25-gauge needle. Nuclei and unbroken cells were removed from the suspension by centrifugation (1000 rpm at 4°C). Membranes were obtained from the supernatant by centrifugation in a Beckman TLA100. non-selective ␤AR antagonist [
125 I]iodocyanopindolol (PerkinElmer Life Sciences) as described previously (6) .
Western Blot-Membrane proteins were prepared from ␤ 2 AR-KO myocytes and adenovirus-infected ␤ 1 /␤ 2 AR-KO myocytes. The myocytes were rinsed with ice-cold 1ϫ PBS before harvesting with 20 mM HEPES, pH 7.4, buffer containing 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml benzamidine. The collected cells were lysed on ice for 30 min, and the unbroken cells and nuclei were cleared by centrifugation at 1000 rpm at 4°C for 5 min. The proteins were separated on 10% SDS-PAGE gels and Western blotted with anti-HA antibody (mouse monoclonal IgG 1 , 1:600 dilution, Covance). After staining with a horseradish peroxidase-conjugated goat-anti mouse IgG antibody (1:1000 dilution, BioRad, Hercules, CA), the Western blot was developed with the ECL kit (Amersham Biosciences).
ELISA Assay-Myocytes were cultured in 12-well plates and infected with the FLAG-␤ 2 AR, HA-␤ 1 AR, or HA-␤ 1 AR-PDZ adenoviruses as described above. Myocytes were incubated in media containing 400 g/ml concanavalin A or control media for 30 min, and then the cells were treated with 10 M isoproterenol for an additional 30 min. Myocytes without isoproterenol stimulation were used as controls. All of the myocytes were fixed with 1ϫ PBS containing 5% paraformaldehyde and stained with anti-FLAG M1 antibody (mouse monoclonal IgG 2b , 1:600 dilution, Sigma) or anti-HA 16b12 antibody (mouse monoclonal IgG 1 , 1:600 dilution, Convance). The myocytes were then stained with horseradish peroxidase-conjugated goat-anti mouse antibody (1:1000, Bio-Rad) and processed for the 1-Step ABTS reaction (Pierce). The reaction was stopped by addition of 2% SDS, and the color density was measured with Softmax (Molecular Devices, Sunnyvale, CA). The data obtained from the isoproterenol-treated myocytes were normalized to that of the controls.
RESULTS
Disruption of the ␤ 1 AR PDZ Motif Leads to Promiscuous G Protein
Coupling-To perform structure-function studies on the ␤ 1 AR, we used recombinant adenovirus to deliver wild type or mutant ␤ 1 ARs into ␤ 1 /␤ 2 AR-knockout (␤ 1 /␤ 2 AR-KO) neonatal cardiac myocytes. An amino-terminal HA epitope was inserted into the mouse ␤ 1 AR (HA-␤ 1 AR) to facilitate immunocytochemical and biochemical studies. To ensure that HA-␤ 1 AR exhibited functional properties similar to those of endogenous ␤ 1 AR in neonatal cardiac myocytes, we infected ␤ 1 /␤ 2 AR-KO myocytes with different titers of recombinant adenovirus expressing HA-␤ 1 AR. Endogenous ␤ 1 AR expression in ␤ 2 AR-KO myocytes is relatively low (148 fmol/mg of membrane protein), but is comparable with that of ␤ 1 AR in the intact ␤ 2 AR-KO mouse heart (Fig. 1A) (6) . The expression of HA-␤ 1 AR in ␤ 1 / ␤ 2 AR-KO myocytes ranged from 5-to 98-fold of that of endogenous ␤ 1 AR, depending on the virus inoculum (Fig. 1A) . Fig. 1B shows the effect of isoproterenol on the contraction rate of ␤ 1 /␤ 2 AR-KO myocytes expressing different levels of HA-␤ 1 AR. The maximum contraction rate increase induced by isoproterenol was dependent on the level of HA-␤ 1 AR expressed (Fig.  1B) . In cells infected with 100 virus particles per cell (m.o.i. of 100), HA-␤ 1 AR gave a response comparable with that observed from endogenous ␤ 1 AR in ␤ 2 AR-KO myocytes (Fig. 1B) .
To study the role of the PDZ motif in ␤ 1 AR function in neonatal cardiac myocytes, we generated a recombinant adenovirus expressing a mutant ␤ 1 AR that lacks a functional PDZ motif (HA-␤ 1 AR-PDZ). HA-␤ 1 AR and HA-␤ 1 AR-PDZ were expressed in ␤ 1 /␤ 2 AR-KO neonatal by infecting myocytes with recombinant adenovirus at a m.o.i. of 100. Both receptors could be efficiently expressed in neonatal myocytes ( Fig. 2A) , and the level of receptor expression was comparable (Fig. 2B) . Figure  2C shows the effect of isoproterenol on the contraction rate of ␤ 1 /␤ 2 AR-KO myocytes expressing either HA-␤ 1 AR or HA-␤ 1 AR-PDZ. The initial maximum contraction rate increase induced by HA-␤ 1 AR-PDZ was similar to that induced by HA-␤ 1 AR. However, after 15 min of stimulation, the contraction rate of HA-␤ 1 AR-expressing myocytes remained above the basal level, while the contraction rate of HA-␤ 1 AR-PDZ-expressing myocytes decreased to below the basal level (Fig. 2C) . The biphasic contraction rate response resulting from stimulation of HA-␤ 1 AR-PDZ is similar to that of endogenous ␤ 2 AR in ␤ 1 AR-KO myocytes (see Fig. 5B and Ref. 8). We also examined cAMP accumulation in cultures of ␤ 1 /␤ 2 AR-KO myocytes expressing either HA-␤ 1 AR or HA-␤ 1 AR-PDZ. In contrast to different contraction rate responses to isoproterenol, the cAMP accumulation was not significantly different between myocytes expressing HA-␤ 1 AR and myocytes expressing HA-␤ 1 AR-PDZ (Fig. 3) . Our previous studies have shown that the biphasic contraction rate response to stimulation of the ␤ 2 AR is due to sequential coupling of the receptor to G s and G i . Therefore, we used pertussis toxin (PTX), a G i protein inhibitor, to examine the role of G i in the HA-␤ 1 AR-PDZ-mediated inhibition of contraction rate in ␤ 1 /␤ 2 AR-KO neonatal myocytes. PTX treatment prevented the secondary decrease in contraction rate mediated by HA-␤ 1 AR-PDZ (Fig. 2D) , and the resulting contraction rate profile was similar to that of cells expressing HA-␤ 1 AR in the absence of PTX (Fig. 2C) . Thus, like the ␤ 2 AR in ␤ 1 AR-KO myocytes, HA-␤ 1 AR-PDZ undergoes sequential coupling to G s and G i in ␤ 1 /␤ 2 AR-KO myocytes.
The ␤ 1 AR PDZ Motif Is Required to Retain the Activated Receptor on the Surface of Neonatal Myocytes-The ␤ 2 AR undergoes rapid and robust agonist-induced internalization in HEK293 cells, whereas agonist-induced internalization of the ␤ 1 AR is more limited (2, 24) . Biochemical studies suggest that receptor endocytosis is necessary for the activation of the G idependent MAPK pathway (25) . Thus, the trafficking of ␤ARs may play a critical role in their specific signaling behavior in mouse neonatal cardiac myocytes. Immunocytochemistry revealed that both HA-␤ 1 ARs and FLAG-tagged ␤ 2 ARs (FLAG-␤ 2 AR) are localized predominantly on the cell surface of neonatal myocytes at steady-state (Fig. 4A) . After isoproterenol stimulation, HA-␤ 1 ARs remained predominantly on the cell surface, whereas significant internalization of the ␤ 2 AR was detected as punctate intracellular staining. Quantitative ELISA assays confirmed that isoproterenol stimulation caused a 22% decrease in cell surface FLAG-␤ 2 ARs in comparison to a 1.7% decrease in cell surface HA-␤ 1 ARs (Fig. 4B) . HA-␤ 1 AR-PDZ also displayed cell surface staining on neonatal myocytes at steady state. However, in contrast to HA-␤ 1 AR, HA-␤ 1 AR-PDZ underwent significant internalization after isoproterenol stimulation (Fig. 4A) , associated with a 11% loss of cell surface receptor by ELISA (Fig. 4B) . These results suggests that the PDZ motif on ␤ 1 AR is required to retain the activated receptor on the cell surface of neonatal myocytes.
Blocking ␤AR Internalization Inhibits the Receptor/G i Coupling in Neonatal Cardiac Myocytes-To examine the role of agonist-induced internalization in ␤ 2 AR function, a nonselective endocytosis inhibitor, concanavalin A (conA), was used to block the receptor internalization in cardiac myocytes. conA treatment reduced ␤ 2 AR internalization by 45% (Fig. 5A and data not shown). Fig. 5B shows the effect of conA on the contraction rate response to isoproterenol mediated by endogenous ␤ 2 AR in ␤ 1 AR-KO myocytes. As previously reported, ␤ 1 AR-KO myocytes display a biphasic contraction rate response after isoproterenol stimulation due to sequential coupling of the ␤ 2 AR to G s and G i (8) . However, the conA-treated ␤ 1 AR-KO myocytes displayed a larger maximum contraction rate response to isoproterenol, and the contraction rate did not drop below basal level (Fig. 5B) . These results suggest that conA treatment enhances coupling to G s and/or inhibits coupling to G i . The role of G i in the conA-treated ␤ 1 AR-KO myocytes was examined with PTX. Additional treatment with PTX did not further augment the maximum contraction rate increase by isoproterenol, nor did it change the contraction rate response profile of the conA-treated ␤ 1 AR-KO myocytes (Fig. 5C ). In contrast, conA did not significantly alter the ␤ 1 AR-mediated contraction rate response to isoproterenol in ␤ 2 AR-KO myocytes (Fig. 6A) . Moreover, conA did not significantly affect the contraction rate response to isoproterenol in wild type myocytes (Fig. 6B) .
We then examined the effect of conA on the contraction rate by isoproterenol in ␤ 1 /␤ 2 AR-KO myocytes expressing ␤ 1 AR-PDZ. In comparison to untreated controls, conA prevented the contraction rate from decreasing below basal level (Fig. 7A) . Moreover, PTX treatment did not alter the contraction rate response to isoproterenol in the conA-treated myocytes (Fig.  7B) . Thus, our observations suggest that conA treatment can block the internalization of ␤ 1 AR-PDZ and ␤ 2 AR and inhibit these receptors from coupling to G i in neonatal cardiac myocytes. Together, these data suggest that receptor internalization may be required for the sequential coupling observed in ␤ 2 AR and ␤ 1 AR-PDZ.
A Membrane-permeable Peptide Containing the ␤ 1 AR-PDZ Motif Affects ␤ 1 AR Signaling in Cardiac Myocytes-To confirm our observations on ␤ 1 AR-PDZ in ␤ 1 /␤ 2 AR-KO myocytes, we used a membrane-permeable peptide (Tat-␤ 1 PDZ) to interfere with the interaction between endogenous ␤ 1 AR and its binding partners in ␤ 2 AR-KO myocytes. Fig. 8A shows the effect of Tat-␤ 1 PDZ on the contraction rate by isoproterenol in ␤ 2 AR-KO myocytes. In comparison to non-treated cells, the Tat-␤ 1 PDZtreated myocytes showed a smaller maximum contraction rate increase, and the contraction rate decreased below basal levels. In contrast, both the control peptides, Tat and Tat-Scr-⑀R, did not significantly change the contraction rate (data not shown and Fig. 8B ). The biphasic contraction rate response in Tat-␤ 1 PDZ-treated ␤ 2 AR-KO myocytes suggests a sequential coupling of ␤ 1 AR-PDZ to both G s and G i . Thus, the role of G i in the Tat-␤ 1 PDZ-treated ␤ 2 AR-KO myocytes was evaluated. PTX treatment caused a greater maximum contraction rate increase in response to isoproterenol and prevented the contraction rate FIG. 5 . The effect of conA treatment on ␤ 2 AR trafficking and signaling in neonatal cardiac myocytes. A, conA blocks FLAG-␤ 2 AR internalization in neonatal cardiac myocytes. ␤ 1 /␤ 2 AR-KO myocytes expressing FLAG-␤ 2 AR (adv:␤ 2 ) were treated with conA (400 g/ml) or control media for 30 min before isoproterenol stimulation. The cells were fixed and stained for immunofluorescence microscopy. B, the effect of conA on ␤ 2 AR-mediated myocyte contraction rate. ␤ 1 AR-KO neonatal myocytes were cultured and treated with either conA (400 g/ml) or control media 30 min before contraction rate experiments as described under "Experimental Procedures." The basal contraction rate of ␤ 1 AR-KO myocytes was not altered significantly by conA treatment. C, the effect of conA treatment on ␤ 2 AR-G i coupling in myocytes. ␤ 1 AR-KO neonatal myocytes were cultured and treated with PTX (0.75 g/ml) or control media for 2.5 h before the addition of conA (400 g/ml). Myocytes were incubated for an additional 30 min before contraction rate experiments were performed as described under "Experimental Procedures." The data in B and C represent the mean Ϯ S.E. of n experiments from at least three different myocyte preparations. *, p Ͻ 0.05; two time-course curves were found to be significantly different by two-way analysis of variance. from decreasing below basal level in ␤ 2 AR-KO myocytes treated with TAT-␤ 1 PDZ (Fig. 8C) . In contrast, the Tat-␤ 1 PDZ peptide had no significant effect on the contraction rate of ␤ 2 AR-KO myocytes stimulated by forskolin (Fig. 8D) . Thus, our results suggest that the peptide Tat-␤ 1 PDZ can selectively modulate the ␤ 1 AR-mediated signaling in cardiac myocytes by competing with the binding of endogenous ␤ 1 ARs to PDZ domain-containing proteins.
DISCUSSION
␤ adrenergic receptors play critical roles in mediating physiologic responses to the hormone epinephrine and the neurotransmitter norepinephrine in animal hearts. Although both ␤ 1 and ␤ 2 ARs are expressed in the hearts and respond to the same physiologic agonists, they show distinct functions in vivo. We have previously shown that ␤ 1 and ␤ 2 ARs display distinct signaling properties in controlling neonatal myocyte contraction rate. Activated ␤ 1 ARs couple to G s , leading to a large increase in contraction rate (8) . In this study, we have found that the PDZ motif on ␤ 1 AR is required to restrict coupling of this receptor to G s in mouse neonatal cardiac myocytes (Figs. 2,  7, and 8) . Mutation of the PDZ motif on ␤ 1 AR or inhibiting the interaction between the ␤ 1 AR and the PDZ domain protein with a cell-permeable peptide enables the receptor to couple to both G s and G i , resulting in a biphasic effect on myocyte contraction rate (Figs. 2 and 8) . Thus, ␤ 1 AR appears to have the structural motifs necessary for efficient coupling to G i in vitro; however, this coupling is inhibited in cardiac myocytes by the association between the ␤ 1 AR PDZ motif and its binding partner. Based on the observed effect of the PDZ mutation on contraction rate in vitro (Fig. 2) , we might expect that a similar mutant expressed in vivo would have a significant and possibly detrimental effect on cardiac function. Therefore, preventing ␤ 1 ARs from coupling to G i may be essential for the physiologic function of this receptor.
Of interest, the effect of the PDZ mutation on contraction rate is not associated with detectable changes in whole cell cAMP accumulation (Fig. 3) . The apparent discrepancy between the results of the contraction rate and the cAMP accumulation assays may be due to technical differences in the assays. To detect cAMP accumulation in myocytes, cultures must be preincubated with a phosphodiesterase inhibitor (isobutylmethylxanthine) to prevent hydrolysis of cAMP. Thus, the cAMP assay conditions will not fully replicate the more FIG. 6 . The effect of conA treatment on ␤ signaling in neonatal cardiac myocytes from ␤ 2 AR-KO and wild type myocytes. A, the effect of conA on ␤ 1 AR-mediated myocyte contraction rate. ␤ 2 AR-KO neonatal myocytes were cultured and treated with either conA (400 g/ml) or control media 30 min before contraction rate experiments as described under "Experimental Procedures." Contraction rate of ␤ 2 AR-KO myocytes was not altered significantly by conA treatment. B, the effect of conA treatment on contraction rate in wild type myocytes. Wild type neonatal myocytes were cultured and treated with either conA (400 g/ml) or control media 30 min before contraction rate experiments as described under "Experimental Procedures." The data represent the mean Ϯ S.E. of n experiments from at least three different myocyte preparations.
FIG. 7.
The effect of conA treatment on the isoproterenol-stimulated contraction rate of ␤ 1 /␤ 2 AR-KO myocytes expressing HA-␤ 1 AR-PDZ. Neonatal myocytes from ␤ 1 /␤ 2 AR-KO mice were cultured and infected with recombinant adenovirus expressing HA-␤ 1 AR-PDZ as described under "Experimental Procedures." A, the effect of conA on ␤ 1 AR-PDZ signaling in myocytes. Neonatal myocytes were treated with either conA (400 g/ml) or control media 30 min before contraction rate experiments as described under "Experimental Procedures." The basal contraction rate of myocytes was not altered significantly by conA treatment. B, the effect of conA on ␤ 1 AR-PDZ coupling to G i in myocytes. Neonatal myocytes were cultured and treated with PTX (0.75 g/ml) or control media for 2.5 h before the addition of conA (400 g/ml). Myocytes were incubated for an additional 30 min before contraction rate experiments were performed as described under "Experimental Procedures." The data represent the mean Ϯ S.E. of n experiments from at least three different myocyte preparations. *, p Ͻ 0.05; two timecourse curves were found to be significantly different by two-way analysis of variance.
physiologic conditions of the myocyte contraction rate assay. Moreover, a recent report demonstrates that discrete microdomains of cAMP accumulation can be detected in neonatal myocytes following adrenergic stimulation (26) . Thus, it is conceivable that the whole-cell cAMP accumulation assay may not be sensitive enough to detect small, but functionally significant focal increases in cAMP adjacent to effector molecules.
In contrast to ␤ 1 ARs, native ␤ 2 ARs undergo sequential coupling to both G s and G i , resulting in a biphasic effect on contraction rate with an initial small increase followed by a sustained decrease. Notably, activated ␤ 2 AR has only a moderate effect on myocyte contraction rate in comparison to activated ␤ 1 AR (Figs. 1 and 5 , and Ref. 8) . It has been recently reported that G s activity may be involved in myocyte apoptosis, whereas activated G i confers a protective effect against myocyte apoptosis (27, 28) . Therefore, although ␤ 2 AR/G i coupling only generates a small negative effect on heart rate (8), its main function may be to activate the anti-apoptosis pathway to protect against the damage induced by chronic ␤ 1 AR activation during prolonged periods of stress. Indeed, moderate overexpression of ␤ 2 AR in the heart of transgenic mice leads to an enhanced cardiac contractility without developing cardiomyopathy, suggesting that ␤ 2 AR can provide contractile support without significant a cardiotoxic consequence (29) . The dual regulation mediated by both ␤ 1 and ␤ 2 ARs in cardiac myocytes represents a sophisticated mechanism critical for the ability of the hearts to respond to, but not be damaged by catecholamines.
There is a growing body of evidence that subtype-specific signaling of GPCRs involves organization of membrane receptors, G proteins, effectors, and regulatory proteins in discrete signaling complexes in the plasma membrane. These complexes are organized by scaffold proteins such as AKAPs (30) and MAGUKs (31, 32) , which contain multiple protein-protein interaction domains that can bind to GPCRs, PKA, protein kinase C, PP2A/PP1, and/or ion channels (11) . Recent studies show that the PDZ motif on ␤ 1 AR can directly interact with two postsynaptic MAGUK proteins, PSD-95 (SAP90) (19) and MAGI-2 (20) . Overexpressing PSD-95 inhibits ␤ 1 AR internalization and promotes the receptor clustering with N-methyl-Daspartate receptors in HEK293 cells (19) . However, overexpressing MAGI-2 enhances ␤ 1 AR internalization and promotes association of the receptor with a cytoskeleton component ␤-catenin but not receptor oligomerization in HEK293 cells (20) . Therefore, the ␤ 1 AR PDZ motif can bind to proteins within distinct signaling complexes that determine the functional properties of the receptor in different cells. Interestingly, ␤ 2 AR also has a carboxyl-terminal PDZ motif that does not interact with SAP or MAGI proteins. Instead, it selectively associates with the Na ϩ /H ϩ exchanger regulatory factor NHERF/EBP50, a distinct PDZ domain-containing protein (17) . This interaction is critical for the receptor recycling after internalization from the cell surface and affects Na ϩ /H ϩ exchange in HEK293 cells (17, 18) . The observed differences in the ␤ 1 AR and ␤ 2 AR PDZ domain-binding proteins may play a role in the functional differences these receptors exhibit in neonatal cardiac myocytes. In agreement with this hypothesis, the ␤ 2 AR undergoes significant internalization while the ␤ 1 AR remains on the cell surface following agonist stimulation in cardiac myocytes. (1 g/ml) or control Tat-Scr-⑀R peptide (1 g/ml) for 25 min before contraction rate experiments as described under "Experimental Procedures." The basal contraction rate of myocytes was not altered significantly by peptide treatment. Tat-␤ 1 PDZ (A) but not Tat-Scr-⑀R (B) treatment significantly changed the isoproterenol-stimulated contraction rate increase in ␤ 2 AR-KO myocytes. C, Tat-␤ 1 PDZ treatment promotes coupling of the ␤ 1 AR to G i . ␤ 2 AR-KO neonatal myocytes were cultured and treated with PTX (0.75 g/ml) or control media for 2.5 h before the addition of conA (400 g/ml). Myocytes were incubated for an additional 30 min before contraction rate experiments were performed as described under "Experimental Procedures." D, the effect of the Tat-␤ 1 PDZ treatment on the contraction rate of ␤ 2 AR-KO myocytes stimulated by forskolin. The data represent the mean Ϯ S.E. of n experiments from at least three different myocyte preparations. *, p Ͻ 0.05; two time-course curves were found to be significantly different by two-way analysis of variance.
Moreover, the ␤ 1 AR-PDZ, like ␤ 2 AR, undergoes significant internalization after agonist stimulation in cardiac myocytes. Therefore, the ␤ 1 AR PDZ motif is critical in determining both the trafficking and the signaling properties of ␤ 1 AR in neonatal cardiac myocytes (Figs. 2 and 4) .
SAP proteins include SAP90 (PSD-95), SAP93, SAP97, and SAP102, whereas MAGI proteins consist of three close relatives, MAGI-1, MAGI-2, and MAGI-3. Sequence analysis predicts that all SAPs and MAGIs can act as binding partners for ␤ 1 AR (19, 20) . Interestingly, MAGI-1 and SAP97 are also expressed in the hearts, and SAP97 associates with cardiac sodium (33) and potassium (21, 22) channels. Studies show that both MAGI-1 and SAP97 also associate with cytoskeleton proteins including ␤-catenin, ␣-actinin-2 and E-cadherin (20, 34, 35) . Thus, SAP97, MAGI-1, or similar proteins may recruit ␤ 1 ARs and ion channels into cytoskeleton-associated signaling complexes in cardiac myocytes. These complexes may not only facilitate the signaling from the bound receptors to downstream ion channels but also tether the receptors on the cell surface by associating with cytoskeleton. Moreover, the cell surface-tethered ␤ 1 ARs signaling complexes could also prevent the receptor from coupling to G i .
Membrane-permeable peptides have recently been used in cell culture and animals to interfere with protein-protein interactions (36) . A membrane-permeable peptide containing the ␤ 1 AR PDZ motif facilitated coupling of endogenous ␤ 1 AR to G i in cardiac myocytes (Fig. 8) confirming the conclusions based on studies of the ␤ 1 AR-PDZ mutant expressed by recombinant adenovirus in ␤ 1 /␤ 2 AR-KO myocytes. This data suggests that the peptide can compete with the binding of endogenous ␤ 1 AR to other cellular components. As a result, ␤ 1 AR is free to couple to more abundant G i in addition to G s in cardiac myocytes. These peptide studies raise the possibility of pharmacologic modulation of GPCR-mediated signaling by disrupting interactions between receptors and scaffolding proteins.
In conclusion, we present evidence that the ␤ 1 AR PDZ motif is essential for the physiologic signaling of this receptor subtype in cardiac myocytes. Disruption of the ␤ 1 AR PDZ motif enabled the receptor to couple to both G s and G i and to enhance receptor internalization after isoproterenol stimulation in neonatal cardiac myocytes. Our observation provides the first clue to the structural basis for the functional differences between ␤ 1 AR and ␤ 2 ARs in neonatal cardiac myocytes.
